Human viral infections: An expanding frontier

Antiviral Research

Volumn 36, Issue 2, 1997, Pages 75-80

  Mahy, Brian W J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Emerging viruses; Host modification; PCR; Vector population; Virus evolution

Indexed keywords

ANTIVIRUS AGENT; VIRUS VACCINE;

ALPHA VIRUS; EVOLUTION; HEPATITIS C VIRUS; HEPATITIS VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS; VIRUS INFECTION;

ANIMALS; DISEASE VECTORS; EVOLUTION, MOLECULAR; HUMANS; SOCIAL BEHAVIOR; VIRUS DISEASES;

ALPHAVIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS;

EID: 0030807769     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)00042-9     Document Type: Review

References (25)

1. Alter M.J., Gallagher M., Morris T.T., Moyer L.A., Meeks E.L., Krawczynski K., Kim J.P., Margolis H.S. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. New. Engl. J. Med. 336:1997;741-746.
2. Cattaneo R., Schmid A., Eschle D., Baczko K., ter Meulen V., Billeter M.A. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell. 55:1988;255-265.
3. Centers for Disease Control and Prevention, 1997. Update: Raccoon rabies epizootic - United States, 1996. Mortality Morbidity Weekly Rep. 45 (51 and 52), 1117-1144.
4. Chan S.Y., Delius H., Halpern A.L., Bernard H. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny and taxonomy. J. Virol. 69:1995;3074-3083.
5. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a DNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
6. Enria D.A., Maiztegui J.I. Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res. 23:1994;23-31.
7. Frey, T.K., 1996. Present status of rubella virus. In: Koprowski, H., Oldstone, M.B.A. (Eds.), Microbe Hunters: Then and Now. Medi-Ed Press, Bloomington, pp. 269-282.
8. Frey T.K. Molecular biology of rubella virus. Adv. Virus Res. 44:1994;69-160.
9. Horimoto T., Kawaoka Y. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza virus. J. Virol. 68:1994;3120-3128.
10. Huggins J.W., Hsiang C.M., Cosgriff T.M., Guang M.Y., Smith J.I., Wu Z.O., LeDuc J.W., Zheng Z.M., Meegan J.M., Wang Q.H., Oland D.D., Gui X.E., Gibbs P.H., Yuan G.H., Zhang T.M. Prospective, double-blind, concurrent, placebo-controlled, clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome (HFRS). J. Infect. Dis. 164:1991;1119-1127.
11. Hughes J.M., Peters C.J., Cohen M.L., Mahy B.W.J. Hantavirus pulmonary syndrome: an emerging infectious disease. Science. 262:1993;850-851.
12. Institute of Medicine, 1992. Emerging Infections: Microbial Threats to Health in the United States. National Academy Press, Washington, DC, 294 pp.
13. Mahy, B.W.J., Murphy, F.M., 1997. Emergence and reemergence of virus infection. In: Mahy, B.W.J., Collier, L.J. (Eds.), Virology. Topley and Wilson's Microbial Infections, vol. 1. Edward Arnold, London.
14. Mahy, B.W.J., Peters, C.J., 1996. Current problems with viral haemorrhagic fevers. In: Koprowski, H., Oldstone, M.B.A. (Eds.), Microbe Hunters: Then and Now. Medi-Ed Press, Bloomington, pp. 257-266.
15. McCormick J.B., King I.J., Webb P.A. Lassa fever: effective therapy with ribavirin. New Engl. J. Med. 314:1986;202-206.
16. Mims C.A. The origin of major human infections and the crucial role of person-to-person spread. Epidemiol. Infect. 106:1991;425-433.
17. Moore P.S., Gao S.J., Dominguez G., Cesarman E., Lungu O., Knowles D.M., Garber R., Pellett P.E., McGeoch D.J., Chang Y. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J. Virol. 70:1996;540-558.
18. Morzunov S.P., Feldmann H., Spiropoulou C.F., Semenova V., Rollin P.E., Ksiazek T.G., Peters C.J., Nichol S.T. A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana. J. Virol. 69:1995;1980-1983.
19. Murphy F.A., Nathanson N. The emergence of new viral diseases: an overview. Semin. Virol. 5:1994;87-102.
20. Nichol S.T., Spiropoulou C.F., Morzunov S., Rollin P.E., Ksiazek T.G., Feldmann H., Sanchez A., Childs J., Zaki S.R., Peters C.J. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science. 262:1993;914-917.
21. Reyes G.R., Purdy M.A., Kim J.P., Luk K.C., Young L.M., Fry K.E., Bradley D.W. Isolation of a DNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 247:1990;1335-1339.
22. Sanchez A., Trappier S.G., Mahy B.W.J., Peters C.J., Nichol S.T. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. USA. 93:1996;3602-3607.
23. Schonberger, L.B., 1998. New variant Creutzfeld-Jakob disease and bovine spongiform encephalopathy. Infect. Dis. Clin. North Am. (in press).
24. Strauss J., Strauss E.G. The alphaviruses: gene expression, replication, evolution. Microbiol. Rev. 58:1994;491-562.
25. Wilesmith J., Wells G.A.H. Bovine spongiform encephalopathy. Curr. Top. Microbiol. Immunol. 172:1991;21-38.